How big is the Alpha Emitter Market?

The Alpha Emitter Market size is expected to reach USD 581.30 million in 2024 and grow at a CAGR of 9.91% to reach USD 932.38 million by 2029. Read More

What is the current Alpha Emitter Market size?

In 2024, the Alpha Emitter Market size is expected to reach USD 581.30 million. Read More

Who are the key players in Alpha Emitter Market?

Alpha Tau Medical Ltd, IBA Radiopharma Solutions, Bayer AG, Actinium Pharmaceuticals Inc., IBA Radiopharma Solutions and RadioMedix Inc. are the major companies operating in the Alpha Emitter Market. Read More

Which is the fastest growing region in Alpha Emitter Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Alpha Emitter Market?

In 2024, the North America accounts for the largest market share in Alpha Emitter Market. Read More

What years does this Alpha Emitter Market cover, and what was the market size in 2023?

In 2023, the Alpha Emitter Market size was estimated at USD 528.89 million. The report covers the Alpha Emitter Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Alpha Emitter Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Alpha Emitter Market Share

Statistics for the 2023 & 2024 Alpha Emitter market share, created by Mordor Intelligence™ Industry Reports. Alpha Emitter share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Alpha Emitter Industry

The alpha emitter market is less competitive and consists of very few major players. Companies like IBA Radiopharma Solutions, Bayer AG, Alpha Tau Medical Ltd, Actinium Pharmaceutical Inc., Telix Pharmaceuticals Ltd, RadioMedix Inc., and Fusion Pharmaceuticals hold a substantial share in the market.